<unk>  is a 150kDa-sized bispecific antibody whose molecular structure allows a high affinity bond to both vascular endothelial growth factor A (VEGF-A) and Angiopoietin (Ang-2). By blocking the action of these two growth factors,<unk>  decreases migration and replication of endothelial cells allowing for stabilization of vascular structures, thereby decreasing vascular leakage.<unk>  has shown improved and sustained efficacy in comparison to agents that only target the VEGF pathway.
Faricimab
Altbib
Odesivimab
Oseltamivir
Maftivimab
Regdanvimab
Atoltivimab
Sotrovimab